2022 Revenues ($USD) : $3,678,805,774
2022 Revenues (foreign currencies) : CHF3,363,900,000
2022 R&D spend : $252,077,865
2022 Number of Employees : 16,733
Fiscal Year End : 3/31/2022
Company CEO : Arnd Kaldowski, CEO

Founded in 1947, Sonova develops hearing instruments and cochlear implants and other products. The Stäfa, Switzerland–headquartered company has a variety of brands. Under the hearing instrument category are the brands Phonak, Unitron and Hansaton. Sonova also has the consumer hearing brand Sennheiser and the Advanced Bionics line of cochlear implants. Serving customers in more than 100 countries, Sonova announced in August 2022 that it plans to expand its footprint in China by acquiring Hysound, a company with approximately 200 clinics in 20 Chinese provinces. The company anticipates that its proposed acquisition of the Hysound chain of audiological clinics in China will close by March 31, 2023, subject to regulatory approval. –BB